Viewing StudyNCT01131364

Home Icon Home Search Icon Search Alerts Icon Stocks Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Main Search All Studies All Organizations Report Bug
View Study With Definitions
Ignite Creation Date: 2024-05-05 @ 10:33 PM
Last Modification Date: 2024-10-26 @ 10:20 AM
Study NCT ID: NCT01131364
Status: TERMINATED
Last Update Posted: 2014-02-25
First Post: 2010-05-25
Brief Title: Combination Therapy of F16IL2 and Doxorubicin in Solid Tumour Patients
Sponsor: Philogen SpA
Organization: Philogen SpA
Overview Dates Organization Conditions Design Enrollment Locations Outcomes

Conditions & Keywords Data

Conditions:
Name
Breast Cancer
Advanced Solid Tumor
Keywords:
Name View
Phase II Breast Cancer Patients Amenable to anthracyclin Therapy View
Interleukin View
IL2 View
F16 View
monoclonal View
antibody View
cytokine View
doxorubicin View
breast cancer View
solid tumour View
Phase I Advanced Solid Tumour Patients View